XML 79 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Revenues        
Product revenue, net $ 3,175,236 $ 1,795,011 $ 4,615,062 $ 3,226,820
Operating expenses        
Cost of sales 606,046 525,138 981,766 936,097
Research and development 66,675 149,029 144,695 304,907
Selling, general and administrative 6,516,160 5,046,174 11,662,603 8,622,754
Selling, general and administrative - related party 0 91,337 0 345,046
Amortization of intangible assets 953,450 534,063 1,528,567 986,020
Total operating expenses 8,142,331 6,345,741 14,317,631 11,194,824
Loss from operations (4,967,095) (4,550,730) (9,702,569) (7,968,004)
Other (expense) income        
Other (expense), net (446,958) (127,569) (642,344) (204,130)
Gain from derecognition of contingent consideration liability 5,199,806 0 5,199,806 0
Gain from warrant derivative liability 0 20,637 1,830 67,989
Total other (expense) income 4,752,848 (106,932) 4,559,292 (136,141)
Net loss $ (214,247) $ (4,657,662) $ (5,143,277) $ (8,104,145)
Weighted average number of common shares outstanding 17,538,148 6,477,004 16,425,990 4,183,591
Basic and diluted net loss per common share $ (0.03) $ (0.72) $ (.31) $ (1.94)